Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 2/2023

01.04.2023

Moses Laser Enucleation of the Prostate (MoLEP): Use of Pulse Modulated Holmium Laser Technology for Prostate Enucleation

verfasst von: Mark A. Assmus, Amy E. Krambeck

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In this review, the current literature available that evaluates the use of Moses pulse-modulated holmium technology for laser enucleation of the prostate will be addressed. Topics include safety and surgical case efficiency, length of post-operative foley catheter and hospital stay, surgical outcomes, and areas of future research.

Recent Findings

Some early retrospective studies and select randomized control trials seek to determine if novel laser technologies can improve peri-operative outcome measures or reduce the morbidity of endoscopic enucleation of the prostate while maintaining or improving the safety profile of holmium laser enucleation of the prostate (HoLEP). Both objective and subjective outcomes of HoLEP are seen to be preserved in patients undergoing Moses laser enucleation of the prostate (MoLEP), with recent studies highlighting high rates of successful same-day catheter removal and same-day discharge in an increasingly wide range of patients.

Summary

Initial studies focusing on Moses laser technology for prostate enucleation are promising. Further high-quality randomized controlled trials evaluating MoLEP are required to clarify the clinical impact of this laser technology on prostate enucleation outcomes as well as comparing to alternative novel benign prostate hyperplasia (BPH) treatments.
Literatur
1.
Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am. 2016;43(3):289–97.PubMedCrossRef
2.
3.
Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-surgical evaluation and treatment. J Urol. 2021;206(4):818–26.PubMedCrossRef
4.
Nickel JC, Aaron L, Barkin J, Elterman D, Nachabe M, Zorn KC. Canadian urological association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update. Can Urol Assoc J. 2018;12(10):303–12.PubMedPubMedCentralCrossRef
5.
6.
Bormashenko E. Moses effect: physics and applications. Adv Colloid Interface Sci. 2019;269:1–6.PubMedCrossRef
7.
Fried NM, Irby PB. Advances in laser technology and fibre-optic delivery systems in lithotripsy. Nat Rev Urol. 2018;15(9):563–73.PubMedCrossRef
8.
Corsini C, de Angelis M, Villa L, Somani BK, Pietropaolo A, Montorsi F, et al. Holmium: yttrium-aluminum-garnet laser with Moses: does it make a difference? Curr Opin Urol. 2022;32(3):324–9.PubMedCrossRef
9.
Ventimiglia E, Traxer O. What is moses effect: a historical perspective. J Endourol. 2019;33(5):353–7.PubMedCrossRef
10.
Ventimiglia E, Villa L, Doizi S, Briganti A, Proietti S, Giusti G, et al. Laser lithotripsy: the importance of peak power and pulse modulation. Eur Urol Focus. 2021;7(1):22–5.PubMedCrossRef
11.
Elhilali MM, Badaan S, Ibrahim A, Andonian S. Use of the moses technology to improve holmium laser lithotripsy outcomes: a preclinical study. J Endourol. 2017;31(6):598–604.PubMedPubMedCentralCrossRef
12.
Ibrahim A, Badaan S, Elhilali MM, Andonian S. Moses technology in a stone simulator. Can Urol Assoc J. 2018;12(4):127–30.PubMedCrossRef
13.
Assmus MA, Lee MS, Krambeck AE. Moses laser enucleation of the prostate (MoLEP). Urol Vid J. 2022;13:10023.
14.
Agarwal DK, Rivera ME, Nottingham CU, Large T, Krambeck AE. Catheter removal on the same day of holmium laser enucleation of the prostate: outcomes of a pilot study. Urology. 2020;146:225–9.PubMedCrossRef
15.
Abdul-Muhsin H, Critchlow W, Navaratnam A, Gnecco J, Tay K, Girardo M, et al. Feasibility of holmium laser enucleation of the prostate as a 1-day surgery. World J Urol. 2020;38(4):1017–25.PubMedCrossRef
16.
Agarwal DK, Large T, Tong Y, Stoughton CL, Damler EM, Nottingham CU, et al. Same day discharge is a successful approach for the majority of patients undergoing holmium laser enucleation of the prostate. Eur Urol Focus. 2022;8(1):228–34.PubMedCrossRef
17.
Assmus MA, Ganesh MB, Lee MS, Large T, Krambeck AE. Contemporary outcomes for patients undergoing concurrent surgeries at the time of holmium laser enucleation of the prostate before and after moses 2.0 BPH mode. J Endourol. 2021;35(S3):S8–13.PubMedCrossRef
18.
Assmus MA, Large T, Lee MS, Agarwal DK, Rivera ME, Krambeck AE. Same-day discharge following holmium laser enucleation in patients assessed to have large gland prostates (>/=175 cc). J Endourol. 2021;35(9):1386–92.PubMedCrossRef
19.
Li J, Cao D, Huang Y, Liu L, Wei Q. Re: Does MOSES technology enhance the efficiency and outcomes of standard holmium laser enucleation of the prostate? Results of a systematic review and meta-analysis of comparative studies. Eur Urol Focus. 2022;8(6):1869–70.PubMedCrossRef
20.
Fallara G, Capogrosso P, Schifano N, Costa A, Candela L, Cazzaniga W, et al. Ten-year follow-up results after holmium laser enucleation of the prostate. Eur Urol Focus. 2021;7(3):612–7.PubMedCrossRef
21.
Kavoussi NL, Nimmagadda N, Robles J, Forbes C, Wang A, Stone B, et al. MOSESTM technology for holmium laser enucleation of the prostate: a prospective double-blind randomized control trial. J Urol. 2021;206(1):104–8.PubMedCrossRef
22.
Nevo A, Faraj KS, Cheney SM, Moore JP, Stern KL, Borofsky M, et al. Holmium laser enucleation of the prostate using Moses 2.0 vs non-Moses: a randomised controlled trial. BJU Int. 2020;127(5):553–9.PubMedCrossRef
23.
Elshal AMSM, El-Tabey NA, Laymon M, Nabeeh A. Randomised trial of bipolar resection vs holmium laser enucleation vs greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU International. 2020;126:731–8.PubMedCrossRef
24.
Assmus MA, Large T, Krambeck A. Holmium laser enucleation of the prostate efficiency by prostate gland size: is there a sweet spot? Uro. 2021;1(4):202–8.CrossRef
25.
Dusing MW, Krambeck AE, Terry C, Matlaga BR, Miller NL, Humphreys MR, et al. Holmium laser enucleation of the prostate: efficiency gained by experience and operative technique. J Urol. 2010;184(2):635–40.PubMedCrossRef
26.
Whiles BB, Martin AJ, Brevik A, Carrera RV, Thompson JA, Molina WR, et al. Utilization of MOSES modulated pulse mode results in improved efficiency in holmium:YAG laser ablation of the prostate. Urology. 2021;149:187–92.PubMedCrossRef
27.
Assmus MAGMB, Lee MS, Large T, Krambeck AE. Contemporary outcomes for patients undergoing concurrent surgeries at the time of holmium laser enucleation of the prostate before and after moses 2.0 BPH mode. J Endourol. 2021;35(53):58–513.
28.
Assmus MA, Lee MS, Sivaguru M, Agarwal DK, Large T, Fouke BW, et al. Laser fiber degradation following holmium laser enucleation of the prostate utilizing Moses technology versus regular mode. World J Urol. 2022;40(5):1203–9.PubMedCrossRef
29.
Large T, Nottingham C, Stoughton C, Williams J Jr, Krambeck A. Comparative study of holmium laser enucleation of the prostate with MOSES enabled pulsed laser modulation. Urology. 2020;136:196–201.PubMedCrossRef
30.
Nottingham CU, Large T, Agarwal DK, Rivera ME, Krambeck A. Comparison of newly-optimized Moses technology versus standard holmium:YAG for endoscopic laser enucleation of the prostate. J Endourol. 2021;35(9):1393–9.PubMed
31.
Enikeev D, Morozov A, Taratkin M, Misrai V, Rijo E, Podoinitsin A, et al. Systematic review of the endoscopic enucleation of the prostate learning curve. World J Urol. 2020;39(7):2427–38.PubMedCrossRef
32.
Gurlen G, Karkin K. Does Holmium laser enucleation of the prostate (HoLEP) still have a steep learning curve? Our experience of 100 consecutive cases from Turkey. Arch Ital Urol Androl. 2021;93(4):412–7.PubMedCrossRef
33.
Yuan QWS, Huang B, Xu Z, Li D, Li J, Fu W, Zhang X. MOSESTM technology for holmium laser enucleation of the prostate a prospective double-blind randomized control trial. Letter Journal of Urology. 2021;206(3):785–6.PubMedCrossRef
34.
Gauhar V, Gilling P, Pirola GM, Chan VW, Lim EJ, Maggi M, et al. Does MOSES technology enhance the efficiency and outcomes of standard holmium laser enucleation of the prostate? Results of a Systematic Review and Meta-analysis of Comparative Studies. Eur Urol Focus. 2022;8(5):1362–9.PubMedCrossRef
35.
Klett DE, Baird B, Ball CT, Dora CD. Does MOSES pulse modulation reduce short-term catheter reinsertion following holmium laser enucleation of the prostate? Investig Clin Urol. 2021;62(6):666–71.PubMedPubMedCentralCrossRef
36.
Comat V, Marquette T, Sutter W, Bernhard JC, Pasticier G, Capon G, et al. Day-case holmium laser enucleation of the prostate: prospective evaluation of 90 consecutive cases. J Endourol. 2017;31(10):1056–61.PubMedCrossRef
37.
Lee SM, Gordon K, McMillan R, Crystal F, Acher P. Day-case holmium laser enucleation of the prostate: feasibility, safety and predictive factors. Ann R Coll Surg Engl. 2018;100(6):475–9.PubMedPubMedCentralCrossRef
38.
Lwin AA, Zeng J, Evans P, Phung MC, Hynes KA, Price ET, et al. Holmium laser enucleation of the prostate is safe and feasible as a same day surgery. Urology. 2020;138:119–24.PubMedCrossRef
39.
Lee MS, Assmus M, Agarwal D, Large T, Krambeck A. A cost comparison of holmium laser enucleation of the prostate with and without Moses™. Urology Practice. 2021;8(6):624–9.PubMedCrossRef
Metadaten
Titel
Moses Laser Enucleation of the Prostate (MoLEP): Use of Pulse Modulated Holmium Laser Technology for Prostate Enucleation
verfasst von
Mark A. Assmus
Amy E. Krambeck
Publikationsdatum
01.04.2023
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 2/2023
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-023-00698-3

Weitere Artikel der Ausgabe 2/2023

Current Bladder Dysfunction Reports 2/2023 Zur Ausgabe

INFLAMMATORY/INFECTIOUS BLADDER DISORDERS (MS MOURAD, SECTION EDITOR)

Inflammatory Complications of Prostatic Artery Embolization: an Up-to-Date Review

OUTCOMES IN FUNCTIONAL UROLOGY (A CAMERON, SECTION EDITOR)

How Do We Assess Success After Surgical Management of Urethral Stricture Disease?

STRESS INCONTINENCE AND PROLAPSE (S REYNOLDS,SECTION EDITOR)

Treatment of Female Stress Urinary Incontinence with Urethral Bulking

POST-PROSTATECTOMY AND ACQUIRED VOIDING DYSFUNCTION (V TSE, SECTION EDITOR)

Pathophysiological Mechanisms Involved in Overactive Bladder/Detrusor Overactivity

OUTCOMES IN FUNCTIONAL UROLOGY (A CAMERON, SECTION EDITOR)

Quality, Value, and Efficacy of Alternative Medicine in the Treatment of Overactive Bladder

BPS/INTERSTITIAL CYTITIS (D CASTRO-DIAZ AND Y IGAWA, SECTION EDITORS)

Botulinum Toxin Therapy for Bladder Pain Syndrome/Interstitial Cystitis

Neu im Fachgebiet Urologie

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise